ABSTRACT Objective: To evaluate the cost-utility of latanoprostene bunod 0.024% as first-line therapy compared to the strategy recommended by the Clinical Protocol and Therapeutic Guidelines for primary open-angle glaucoma of the Brazilian Unified Health System. Methods: A cost-utility analysis was conducted using a hypothetical cohort and a Markov model. In the base-case scenario, the treatment strategy recommended by the Clinical Protocol and Therapeutic Guidelines was adopted, initiating therapy with timolol 0.5%. If the target intraocular pressure was not achieved, dorzolamide […]

ABSTRACT Objective: To evaluate the impact of selective laser trabeculoplasty (SLT) on resource savings and medication costs. Methods: Retrospective study of patients with open-angle glaucoma (OAG) who underwent SLT as a replacement therapy for eye drops and were followed for up to 1 year. The ability to reduce intraocular pressure (IOP) and the amount of eye drops were evaluated, as well as the monthly cost of medications during the follow-up. The annual cost of medications was also calculated. The results […]